BenzingaTue, 12 May 2026 18:27:41 GMTAlkermes Gains Momentum After Sleep Disorder Trial Clears Key HurdlesALKS-0.41%
BenzingaWed, 06 May 2026 17:54:10 GMTAlkermes Analysts Increase Their Forecasts Following Strong Q1 ResultsALKS-0.41%
Zacks Investment ResearchWed, 06 May 2026 17:10:18 GMTAlkermes' Q1 Earnings & Revenues Beat Estimates, Stock RisesALKS-0.41%
Seeking AlphaWed, 06 May 2026 11:30:08 GMTAlkermes: A Sleep Medicine Platform Hidden Inside A Mature CNS CompanyALKS-0.41%
Seeking AlphaTue, 05 May 2026 19:41:25 GMTAlkermes plc (ALKS) Q1 2026 Earnings Call TranscriptALKS-0.41%
Zacks Investment ResearchTue, 05 May 2026 14:36:19 GMTAlkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesALKS-0.41%
Zacks Investment ResearchTue, 05 May 2026 13:26:39 GMTAlkermes (ALKS) Reports Q1 Loss, Beats Revenue EstimatesALKS-0.41%
Zacks Investment ResearchTue, 28 Apr 2026 15:09:52 GMTEarnings Preview: Alkermes (ALKS) Q1 Earnings Expected to DeclineALKS-0.41%
Zacks Investment ResearchTue, 28 Apr 2026 14:56:28 GMTWall Street Analysts Believe Alkermes (ALKS) Could Rally 29.14%: Here's is How to TradeALKS-0.41%
Zacks Investment ResearchFri, 27 Mar 2026 16:32:09 GMTWhy Is Alkermes (ALKS) Down 2.6% Since Last Earnings Report?ALKS-0.41%
Zacks Investment ResearchWed, 11 Mar 2026 10:15:47 GMTNew Strong Sell Stocks for March 11thALKS-0.41%
Zacks Investment ResearchThu, 26 Feb 2026 17:40:29 GMTAlkermes Down Despite Q4 Earnings Beat, Announces Leadership ChangeALKS-0.41%
Zacks Investment ResearchWed, 25 Feb 2026 18:30:37 GMTAlkermes (ALKS) Reports Q4 Earnings: What Key Metrics Have to SayALKS-0.41%
Zacks Investment ResearchWed, 25 Feb 2026 18:15:57 GMTAlkermes (ALKS) Q4 Earnings and Revenues Top EstimatesALKS-0.41%
Seeking AlphaWed, 25 Feb 2026 17:47:49 GMTAlkermes plc (ALKS) Q4 2025 Earnings Call TranscriptALKS-0.41%
